| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063946 Human pluripotent hematopoietic colony stimulating factor, method of production and use |
| 03/24/2005 | CA2578375A1 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | CA2538076A1 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516928A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 03/23/2005 | EP1516629A2 Humanized anti CD-11a antibodies |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516055A2 Fiber shaft modifications for efficient targeting |
| 03/23/2005 | EP1516047A1 Purified pkb ser 473 kinase and uses thereof |
| 03/23/2005 | EP1516046A2 Genes encoding baeyer-villiger monooxygenases |
| 03/23/2005 | EP1516044A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 03/23/2005 | EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515738A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 03/23/2005 | EP1114166B1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2005 | EP1012311B1 G protein chimeras |
| 03/23/2005 | EP0937104B1 Endothelium specific expression regulated by epcr control elements |
| 03/23/2005 | EP0845005B1 Traf inhibitors |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0674712B1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 03/23/2005 | EP0672146B1 Biocidal chitin binding proteins |
| 03/23/2005 | EP0662092B1 Activity-dependent neurotrophic factor |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599795A Crystal harvest from fermentation broth |
| 03/23/2005 | CN1599755A Antibodies against caspase-8, their preparation and use |
| 03/23/2005 | CN1599754A Anti-TRAIL-R antibodies |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599747A Isolation of lectins |
| 03/23/2005 | CN1597964A Expression and purification of M protein in recombined SARS coronary virus |
| 03/23/2005 | CN1597960A Code sequence of chalkane synthetase in butterfly orchid and its application |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597950A Icam-4 materials and methods |
| 03/23/2005 | CN1597928A Process for raising yield of glutamine transaminase prepared by fermination process by adding amine hydrocarbon |
| 03/23/2005 | CN1194090C Growth factor and genetic sequence for encoding same |
| 03/23/2005 | CN1194089C large wasp sedative peptide precursor gene and its coded polypeptide and preparation |
| 03/23/2005 | CN1194016C New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 03/23/2005 | CN1194010C Human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 03/23/2005 | CN1194008C Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 03/22/2005 | US6870076 Homeobox genes encoding proteins participating in differentiation |
| 03/22/2005 | US6870032 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6869774 Methods of synthesizing cell-free protein |
| 03/22/2005 | US6869608 Peptides derived from a retrovirus of the HIV group and their use |
| 03/22/2005 | CA2135630C Hiv protein epitopes immunologically homologous to hla |
| 03/22/2005 | CA2127541C Recombinant swinepox virus |
| 03/22/2005 | CA2103059C Method for making humanized antibodies |
| 03/17/2005 | WO2005024428A1 Novel high throughput screening method of drug for physiologically active protein |
| 03/17/2005 | WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | WO2005024031A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof |
| 03/17/2005 | WO2005024015A1 Expression vector |
| 03/17/2005 | WO2005024012A1 Increased expression of a modified polypeptide |
| 03/17/2005 | WO2005024000A1 Methods for producing recombinant proteins |
| 03/17/2005 | WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 03/17/2005 | WO2005023990A2 Trans-splicing mediated photodynamic therapy |
| 03/17/2005 | WO2005023979A2 Isolated s. mansoni nucleic acid molecules and uses thereof |
| 03/17/2005 | WO2005023870A1 ANTIBODY RECOGNIZING TGF-β ACTIVATION CONTROLLING REGION SECTION |
| 03/17/2005 | WO2005023205A2 Compositions and methods for yersinia pestis treatment |
| 03/17/2005 | WO2004099424B1 Enrichment of enzymatic cleavage products |
| 03/17/2005 | WO2004074461A3 Production of modified glycoproteins having multiple antennary structures |
| 03/17/2005 | WO2004050846A3 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 03/17/2005 | WO2004039963A3 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (ser 1101/ser1149) and uses thereof |
| 03/17/2005 | WO2003097811A3 Cellular gene targets for controlling cell growth |
| 03/17/2005 | WO2003078575A3 Molecular switches and methods for making and using the same |
| 03/17/2005 | WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 03/17/2005 | US20050060776 Expression of biologically active polypeptides in duckweed |
| 03/17/2005 | US20050060773 Expression vector comprising nucleotide sequences coding gene associated with plant dwarfing (RHT) for use as tool in establishing seedling development in plants |
| 03/17/2005 | US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 03/17/2005 | US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents |
| 03/17/2005 | US20050059622 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 03/17/2005 | US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059142 Bioreactor for use in clearing of waste water that could be used in food, medical, microbiological and petrochemical industries; bioremediation |
| 03/17/2005 | US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells |
| 03/17/2005 | US20050059118 Hyaluronan receptor for endocytosis |
| 03/17/2005 | US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders |
| 03/17/2005 | US20050059109 Methods and compositions for polypeptide engineering |
| 03/17/2005 | US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance |
| 03/17/2005 | US20050059102 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/17/2005 | US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
| 03/17/2005 | US20050059082 Method for producing protein libraries and for selecting proteins from said libraries |
| 03/17/2005 | US20050059079 Expression vector comprising nucleotide sequences associated with neuropsychological disruption for use in diagnosis, prevention and treatment of schizophrenia, mood and bipolar disorders |
| 03/17/2005 | US20050059053 Generating plants comprising polypeptides with enhanced properties; directed evolution of proteins; bioreactor and heterologous gene expression |
| 03/17/2005 | US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits |
| 03/17/2005 | US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy |
| 03/17/2005 | US20050058688 Device for the treatment and prevention of disease, and methods related thereto |
| 03/17/2005 | US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor |
| 03/17/2005 | US20050058660 Novel surface antigen |
| 03/17/2005 | US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors |
| 03/17/2005 | US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases |
| 03/17/2005 | US20050058651 Compositions and methods to prevent metastasis from primary malignancies |
| 03/17/2005 | US20050058648 Antibodies against caspase-8, their preparation and use |